PET Imaging of Cancer Patients Using 68Ga-DOTA-Siglec-9
NCT05212103 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2024-12-04
Summary
This is a scientific study to determine expression of vascular adhesion protein 1 (VAP-1) in cancer patients by 68Ga-DOTA-Siglec-9 positron emission tomography/computed tomography (PET/CT) before and after cancer treatment.
Conditions
- Acute Myeloid Leukemia
- Melanoma
- Non Small Cell Lung Cancer
Sponsors & Collaborators
-
Turku University Hospital
lead OTHER_GOV
Principal Investigators
-
Anne Roivainen · Turku University Hospital, Turku PET Centre
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-09-01
- Primary Completion
- 2026-12-31
- Completion
- 2026-12-31
Countries
- Finland
Study Locations
More Related Trials
-
An International Study on the Use of PET/CT in Radiotherapy Planning in Low and Middle Income Countries
NCT02247713 ·Status: UNKNOWN
-
PET Imaging of Solid Tumors by a Novel Tracer, 68Ga-FAPI
NCT05172310 ·Status: RECRUITING ·Phase: PHASE1
-
FLT-PET/DW-MRI for Detection of Brain Metastases and Early Therapy Evaluation in Patients With Small Cell Lung Cancer
NCT02995902 ·Status: COMPLETED ·Phase: NA
-
68Ga-FAPI-RGD PET/CT for Dual Integrin αvβ3 and FAP-targeted Imaging in Patients With Various Types of Cancer and Compared With 18F-FDG
NCT05543317 ·Status: COMPLETED ·Phase: NA
-
PET Image Exploration of Novel Tracer [68Ga]-FAPI-JNU Imaging Studies in Patients with Malignant Tumors
NCT06684028 ·Status: RECRUITING ·Phase: NA
-
68Ga-BNU-PSMA PET/CT in Patients With Various Types of Cancer
NCT04525612 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Clinical Application of 68Ga-FAPI PET Imaging in Detection of Ovarian Cancer Recurrence
NCT05856409 ·Status: RECRUITING
-
68Ga-FAPI-46 PET for Imaging of FAP Expressing Cancer
NCT05160051 ·Status: COMPLETED ·Phase: PHASE2
-
FLT-PET/MRI for Early Response Monitoring to Novel Cancer Therapeutic Agents
NCT02055586 ·Status: COMPLETED
-
Measurement of Head and Neck Tumor Hypoxia With PET-MRI
NCT05246475 ·Status: RECRUITING ·Phase: NA
-
68Ga-DOTA-NI-FAPI04 PET/CT in Patients With Various Types of Cancer
NCT06455761 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
68Ga-FAP-CHX PET/CT : Dosimetry and Preliminary Clinical Translational Studies
NCT05506566 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
68Ga-DOTA-F2 PET/CT in Patients With Various Types of Cancer
NCT05637034 ·Status: UNKNOWN ·Phase: NA
-
Image and Dosimetry Related Research of Department of Medical Physics, Cross Cancer Institute
NCT00314470 ·Status: COMPLETED
-
⁸⁹Zr-Df-IAB22M2C (CD8 PET Tracer) for PET/CT in Patients With Metastatic Solid Tumors
NCT03802123 ·Status: COMPLETED ·Phase: PHASE2
-
Comaprison of 68Ga-FAP-2286 and 18F-FDG PET/CT in Patients With Various Types of Cancer
NCT05392205 ·Status: COMPLETED ·Phase: NA
-
Efficacy of PET/MRI in Detecting Metastatic Disease in Endometrial Cancer
NCT02765698 ·Status: TERMINATED
-
PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis Therapy
NCT00019565 ·Status: COMPLETED ·Phase: PHASE1
-
68Ga-FAP-RGD PET/CT : Dosimetry and Preliminary Clinical Translational Studies
NCT05515783 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Imaging of Primary or Recurrent Breast Cancer With 18F-FluorThanatrace PET/CT
NCT03846167 ·Status: ACTIVE_NOT_RECRUITING
-
Comparison Study Between PET/CT and Whole-Body Diffusion Weighted MRI in the Detection of Distant Malignancies
NCT06205901 ·Status: NOT_YET_RECRUITING
-
68Ga-PFA2 PET Imaging for the Diagnosis of Annexin A2-Positive Tumors
NCT07331532 ·Status: RECRUITING
-
18F-FDG PET/CT Versus 18F-FDG PET/MRI in Detecting Locoregional Recurrence 3 Months After CRT in Head and Neck SCC
NCT04196985 ·Status: UNKNOWN ·Phase: NA
-
Imaging of in Vivo Sigma-2 Receptor Expression With 18F-ISO-1 Positron Emission Tomography in Metastatic Breast Cancer
NCT03057743 ·Status: TERMINATED
-
[18F]-DPA-714 PET/CT (Positron Emission Tomography/Computerized Tomography) in Triple Negative Breast Cancers
NCT04320030 ·Status: COMPLETED ·Phase: PHASE2